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Abstract
Introduction
Despite widespread recommendations for colorectal can-
cer screening, the U.S. screening rate is low. The objectives
of this study were to describe the rates and predictors of
colorectal cancer screening use by examining groups in two
categories — 1) those who have ever been screened and 2)
those with up-to-date screening — and to assess whether
trends and predictors change over time.
Methods
We analyzed data from the 2000 and 2003 National
Health Interview Surveys about the use of fecal occult
blood tests, sigmoidoscopies, and colonoscopies for adults
aged 50 years and older and without a history of colorectal
cancer (N = 11,574 in 2000 and N = 11,779 in 2003).
Results
Rates in the 2000 study population of those who have
ever been screened for colorectal cancer (53%) had
increased in the 2003 study population (55%) as had the
rates in the 2003 study population of those with up-to-date
colorectal screening (53%) compared with the rates in the
2000 study population (38%). Among those who were ever
screened, 76% were up-to-date with screening in 2003,
compared with 68% in 2000. There was increased use of
colonoscopies but decreased use of fecal occult blood tests
and sigmoidoscopies. Individuals were more likely to be
up-to-date with screening if they had higher income, high-
er education, insurance coverage, a usual source of care,
and a dental visit in the last year than if these predictors
were not evident. Since 2000, these predictors of colorectal
cancer screening use have remained stable.
Conclusion
Although there has been relatively limited success in
increasing overall screening, it is encouraging that most
people in the group of those who have ever been screened
are up-to-date with colorectal cancer screening. Predictors
for colorectal screening were stable over time despite
changes in screening policies and rates. Further research is
needed to uncover barriers to colorectal cancer screening.
Introduction
Although colorectal cancer (CRC) is a common cancer in
both men and women in the U.S. and although screening
for CRC reduces mortality and is recommended by several
professional organizations (e.g., American College of
Gastroenterology, American Cancer Society) (1-5), the
screening rate for CRC is low compared with screening
rates for other cancers, such as breast and cervical (6-10).
Measuring CRC screening rates is complex because multi-
ple tests are used, and recommended intervals between
tests vary. Studies that have examined predictors of CRC
screening use have included individual characteristics
(e.g., sociodemographic, behavior, risk factors) and health
care system elements (e.g., having medical insurance, hav-
ing a physician recommendation, having a usual source of
care) (11,12). However, relatively little is known about
whether the rates and predictors of CRC screening change
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over time. Understanding current screening rates and pre-
dictors is critically important because of recent changes in
CRC screening policies. For example, an increasing num-
ber of state mandates require private insurers to cover
CRC screenings (13), and the 2000 enactment of Medicare
coverage for CRC screening (14) enables screening for
adults aged 65 years and older.
The objectives of this study were to examine rates and
predictors of CRC screening use by focusing on people who
have ever been screened and those who are up-to-date with
screening and to assess whether use rates and predictors
changed from 2000 to 2003. We recognized that frequency
of use implies test availability and availability of physi-
cians with required training and specialty for invasive
tests (e.g., sigmoidoscopies, colonoscopies). This study
updates national estimates of screening rates (6,9) and
predictors of CRC screening by using nationally represen-
tative data from the 2000 and 2003 National Health
Interview Surveys (NHIS) (15,16). This study contrasts
with previous studies of CRC screening in the following
ways: 1) it focuses on two groups (those who have ever been
screened and those with up-to-date screening) and exam-
ines differences in CRC screening behavior among these
two groups; 2) it uses variables to examine CRC screening
behavior and includes whether tests were used alone or in
combination; 3) it assesses and statistically tests whether
CRC screening use and predictors changed from one peri-
od of time to the next by examining data from 2000 and
2003. Other studies examine screening trends (9,13), but
to our knowledge, this is the first study to empirically test
whether there were differences in rates and predictors of
CRC screening use between 2 years.
Methods
Data and sample
Analysis for this study was based on data from the 2000
and 2003 NHIS, which are nationally representative in-
person household surveys of noninstitutionalized civilians
conducted by the National Center for Health Statistics,
Centers for Disease Control and Prevention (15,16). The
NHIS collects information on household composition,
income, assets, sociodemographic characteristics, health
status and activity limitations, health care access and use,
insurance, health behaviors, and other variables.
The NHIS Cancer Control Supplement, cosponsored by
the National Cancer Institute (15), collects information on
cancer behavior risk factors and cancer screening. A com-
plete Cancer Control Supplement survey was adminis-
tered in 2000. In 2003, selected cancer screening questions,
including those about CRC, were repeated. The 2000 NHIS
included 100,618 adults and children, and the household
response rate was 88.9%. The 2003 NHIS included 92,148
adults and children, and the response rate was 89.2%. For
purposes of this study, we analyzed adults aged 50 years
and older without a history of colorectal cancer. The 2000
sample for this study included 11,574 individuals, and the
2003 sample included 11,779 individuals.
Outcome variables
NHIS respondents aged 40 years and older were asked if
they had ever had 1) a home fecal occult blood test (FOBT)
and 2) a colorectal examination (sigmoidoscopy,
colonoscopy, or proctoscopy). If respondents replied that
they had ever had any of the tests, they were asked to iden-
tify the name of the test or examination. Respondents were
asked the month and year they had their last test. If test
date information was unknown, a follow-up question was
asked to identify the time frame of the most recent exami-
nation. Possible responses included the following: 1) 1 year
ago or less, 2) 1 to 2 years, 3) 2 to 3 years, 4) 3 to 5 years,
5) 5 to 10 years, and 6) more than 10 years ago.
We focused on 1) people who were ever screened for CRC
and 2) people who were up-to-date for CRC screening. The
CRC tests included in our analysis were home FOBT, sig-
moidoscopy, and colonoscopy performed for any reason on
adults aged 50 and older. We specified adults aged 50
years and older as our study sample, and they were classi-
fied as the subpopulation in the survey estimation. Adults
aged 40 to 49 were not included in our subpopulation
because, while they may be at high risk for CRC, they were
not the focus of this study. Double-contrast barium enema
tests were not analyzed because those data are not collect-
ed in the NHIS. Proctoscopy was excluded because it is not
currently recommended as a CRC test (4).
Individuals who have ever been screened
Respondents were classified as ever screened if the per-
son had ever been screened by using any of the three tests
(home FOBT, sigmoidoscopy, or colonoscopy). We used the
following detailed, mutually exclusive categories based on
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FOBT), 4) both FOBT and sigmoidoscopy, or 5) do not
know or other test.
Individuals who are up-to-date with screening
Respondents were classified as being up-to-date with
screening if they followed screening guidelines recom-
mended by the American Cancer Society (4) by having a
home FOBT test in the past 12 months, a sigmoidoscopy in
the last 5 years, or a colonoscopy in the last 10 years. We
analyzed patterns of up-to-date screening by using the fol-
lowing mutually exclusive groups: 1) those not screened
within the recommended time frame, 2) those screened
only by FOBT in the last 12 months, 3) those screened only
by sigmoidoscopy in the last 5 years, 4) those screened by
colonoscopy (with or without FOBT) in the last 10 years,
and 5) those who had both FOBT and sigmoidoscopy
(FOBT in the last 12 months and sigmoidoscopy in the last
5 years).
Factors associated with screening use
The conceptual framework for the study was based on a
behavioral model of health care use which is one of the
most frequently used frameworks for analyzing factors
associated with patient use of health care services. The
model suggests that patients’ use of health care services is
a function of their predisposition to use services, factors
that enable use of services, and their need for care (17,18).
We hypothesize that CRC screening use is associated with
individual-level variables that represent predisposing,
enabling, and need factors.
The predisposing factors were sociodemographic charac-
teristics, such as age (50–64, 65–74, >75), sex, race and
ethnicity (Hispanic, white, African American, and Asian or
other), household income (% of federal poverty level cate-
gorized into the following groups: low [less than 200%],
medium [200%–399%], and high [400% or more]), educa-
tion (less than high school graduate, high school graduate,
college graduate or more), and an individual’s use of pre-
ventive services (defined by had or did not have a dental
check-up in the past year). The enabling factors were hav-
ing health insurance coverage (private, Medicare,
Medicaid or other public insurance, or uninsured) and hav-
ing a usual source of care. Need factors included the fol-
lowing: 1) behavioral risk factors (alcohol consumption
>720 drinks per year for men or >360 drinks per year for
women, smoking, and lack of physical activity); 2) being
overweight or obese (a body mass index [kg/m2] of 25 or
more; 3) self-reported chronic conditions (diabetes, arthri-
tis, ulcers, cardiovascular disease, hypertension, asthma or
emphysema); and 4) self-reported health status (very good,
good, fair, poor). We analyzed the categorical version of
these factors in bivariate analysis. Selected variables were
entered in the logistic regression in the form of continuous
(age, education, number of behavioral risk factors, number
of chronic conditions) or ordinal (household income) when
appropriate for parsimony and efficiency.
Statistical analyses
We hypothesized that these individual-level predispos-
ing, enabling, and need variables would be associated with
CRC screening use. We used X2 tests and logistic regres-
sions analyses to examine associations between individual
characteristics and CRC screening use. Independent vari-
ables for regression models were chosen based on theory,
statistical significance, and parsimony. We discuss results
as statistically significant when P < .05. All regression
analyses used sampling weights to reflect the U.S. civilian,
noninstitutionalized population and standard error adjust-
ment to account for the complex survey design. All calcu-
lations were performed using Stata version 8 (StatCorp,
College Station, Tex).
We used the Chow test to investigate whether specific
predictors have different effects across years (21-24). The
advantage of the Chow test is that it allows statistical
analysis to show whether coefficients are different rather
than relying on estimates. The original Chow test uses an
F test for detecting differences between coefficients in sep-
arate regressions (19). The F test evaluates all coefficients
together and was initially designed for linear models. In
this study, we adopted an alternative approach that has
been shown to be equivalent to the original Chow test and
that allows flexibility to test whether individual factors
have different effects across years (20-22). By using the
2000 and 2003 pooled NHIS data, we estimated models of
screening use by adding a dummy variable for year and
interactions between this dummy variable and other inde-
pendent variables.
Equation (1) Y = α+β * X+α’ * D+β’ * D*X+u,
where Y = probability of screening for an individual or
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probability of being up-to-date with screening,
X = a vector of independent variables,
D = a dummy variable indicating the year 2003,
D*X = interaction terms between the dummy variable
and independent variables,
α, β, α’, β’ = parameters characterizing this function to be
estimated,
u = error term.
Testing whether coefficients in the 2000 model are equal
to coefficients in the 2003 model is equivalent to testing
coefficients of interaction terms being zero, β’= 0. As shown
in equations 1a and 1b, coefficients of the interactions, β’,
represent the differences between the 2000 and 2003 mod-
els. For the purpose of testing whether coefficients changed
between 2000 and 2003, the models were fitted using a lin-
ear probability model to avoid complexity of interpreting
the interaction terms in nonlinear models (23).
Equation (1a), Year 2000, D = 0:  Y = α+β*X+u
Equation (1b), Year 2003, D =1:   Y = (α+α’) + (β+β’)*X+u
Results
Rates of screening use in 2000 and 2003
We observed increasing rates of people having ever been
screened and people having up-to-date screening from
2000 to 2003 (Table 1). In 2003, the ever screened rate was
55%, up from 53% in 2000 (P = .10). Among the total study
population, 42% were up-to-date with screening in 2003,
up from 36% in 2000 (P = .03). Among those screened, 76%
(4913/6466) were up-to-date with screening, up from 68%
(4146/6088) in 2000 (P = .01).
Among the test categories analyzed for the ever screened
group, colonoscopy (with or without FOBT) is the only test
that increased in use with rates increasing from 38% in
2000 to 53% in 2003 (P = .02). Other tests showed a
decrease in use, although the trend was not statistically
significant.
In up-to-date screening behavior, trends were not statis-
tically significant except for a decrease in sigmoidoscopy
use (P = .01). There was increased use of colonoscopy
screening between 2000 and 2003 (P = .05) and decreased
use of FOBT (P = .08) and the combination of FOBT and
sigmoidoscopy (P = .13).
Predictors of screening use in 2003
Bivariate associations between individual characteristics
and CRC screening use are presented in Table 2. Because
2003 and 2000 results were similar, we only describe 2003
results here. Individuals were more likely to be ever
screened by any CRC test if they had a higher level of
household income (P = .04), had a dental visit in the last
year (P = .01), and had a usual source of care (P = .04).
Individuals were more likely to be up-to-date with screen-
ing if they were white (P = .04), had a dental visit in the last
year (P < .001), and had a usual source of care (P = .01).
Results of the multivariate regressions (Tables 3 and 4)
were similar to the bivariate associations seen in Table 2.
Obesity (measured by body mass index) and self-reported
health status were excluded from the regression model
because they were not significantly associated with CRC
screening use.
In 2003, individuals were more likely to be ever screened
(Table 3) if they were older (odds ratio [OR], 1.04; 95% CI,
1.03–1.05; P < .001), had higher household income (OR,
1.06; 95% CI, 1.05–1.08; P < .001), had higher education
levels (OR, 1.06; 95% CI, 1.05–1.08; P < .001), had insur-
ance coverage (OR, 1.61; 95% CI, 1.27–2.05; P < .001 for
private insurance; OR, 1.41; 95% CI, 1.06–1.87; P = .02 for
Medicare; OR, 1.99; 95% CI, 1.44–2.50; P < .001 for
Medicaid or other public insurance), had a usual source of
care (OR, 2.06; 95% CI, 1.63–2.61; P < .001), had a dental
visit in the past year (OR, 1.43; 95% CI, 1.28–1.61; P <
.001), and had more than one chronic condition (OR, 1.37;
95% CI, 1.31–1.44; P < .001). Individuals were less likely to
be screened if their race and ethnicity was Asian or other
rather than white (OR, 0.44; 95% CI, 0.29–0.65; P < .001)
and if they had more than one behavioral risk factor (OR,
0.81; 95% CI, 0.75–0.87; P < .001).
In 2003, individuals were more likely to be up-to-date
(Table 4) with screening if they had higher household
income (OR, 1.03; 95% CI, 1.01–1.06; P = .01), higher edu-
cation (OR, 1.04; 95% CI, 1.00–1.07; P = .007), insurance
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insurance; OR, 2.07; 95% CI, 1.34–3.19; P < .001 for
Medicare; OR, 2.18; 95% CI, 1.42–3.35; P < .001 for
Medicaid or other public insurance), a usual source of care
(OR, 2.59; 95% CI, 1.70–3.94; P < .001), and a dental visit
in the past year (OR, 1.47; 95% CI, 1.21–1.78; P < .001).
Predictors between 2000 and 2003
We examined whether there was a change in predictors
by comparing the coefficients of the 2000 and 2003 models.
Most predictors showed little effect on CRC screening use
and were not statistically different between 2000 and
2003. In the ever screened group, there were two factors
with a stronger effect in 2003 than in 2000, and these were
having higher income (P = .003 in 2000 and P < .001 in
2003) and having Medicaid or other public insurance (P =
.02 in 2000 and P < .001 in 2003) (Table 3). In the up-to-
date screening group, factors with a stronger effect in 2003
than in 2000 were income level (P = .10 in 2000 and P = .01
in 2003), education level (P = .02 in 2000 and P = .007 in
2003), and having insurance (private insurance P = .07 in
2000 and P = .01 in 2003; Medicare P = .05 in 2000 and P
< .001 in 2003; and Medicaid and other public insurance P
= .66 in 2000 and P < .001 in 2003) (Table 4).
Predictors that remained the same for 2000 and 2003 for
the ever screened group were age, having a usual source of
care, having a dental visit in past year, having more than
one behavioral risk factor, and having more than one
chronic condition. Predictors that remained the same for
the up-to-date screening group were having a usual source
of care and having a dental visit in the previous year.
Discussion
This study examined the rates and predictors of ever
screened and up-to-date screening groups by using the
most recent available national data, the 2000 and 2003
NHIS (15,16). In addition, we assessed whether predictors
changed over time. We found that rates of ever screened
and up-to-date screening increased by a modest amount
between 2000 and 2003. Less than half the study popula-
tion was up-to-date with screening (36% in 2000 and 42%
in 2003). However, of the people who were ever screened,
most are up-to-date on screening (68% in 2000 and 76% in
2003). We found that colonoscopy was the test used most
frequently in both years. For both the ever screened and
up-to-date groups we found an increase in rates of
colonoscopy screening (P = .02 for the ever screened group
and P = .05 for the up-to-date group) but a decrease in
rates of use for FOBT (P = .08) and sigmoidoscopy (P = .01)
for the up-to-date group.
Our findings about factors associated with up-to-date
screening were consistent with existing literature. In 2003,
the most influential socioeconomic health status predictors
were 1) a usual source of care and insurance coverage, 2) a
dental visit in the last year, 3) higher education, and 4)
higher income. We found that among the insured there
was little difference in the rates of CRC screening among
privately insured, Medicare enrollees, and Medicaid or
other public insurance enrollees.
We speculated that some predictors of CRC screening
use may change over time because of changes in screening
coverage and policies. For example, the effect of private
insurance coverage might be stronger in 2003 than it was
in 2000 because more states had laws requiring private
health insurers to cover CRC screening (from seven states
in 2000 to 18 states in 2003) (13). We also anticipated that
the effect of Medicare coverage might be stronger in 2003
than in 2000 because of the 2000 enactment of Medicare
coverage for colonoscopy screening. However, we did not
find that having private insurance or Medicare coverage
that covers CRC screening created statistically different
results for 2003 compared with 2000. On the other hand,
we found that positive effects of Medicaid and other public
insurance coverage on CRC screening use was stronger in
2003 than in 2000. Medicaid coverage for CRC screening
varies by state and is not standardized; further assess-
ments are required to draw a conclusion about whether the
observed differences in Medicaid coverage between the 2
years are due to changes in Medicaid coverage or a spill-
over effect from the private and Medicare sectors to pro-
mote Medicaid coverage for CRC screening.
This study demonstrates how CRC screening use can be
measured, a challenge faced by all CRC screening studies.
There have been efforts to develop standardized self-
reporting measures for CRC screening behavior to improve
the quality of survey data (24). Because of the variety of
CRC tests and screening time frames, there is a need to
determine CRC test categories for individual tests and for
combinations of tests. NHIS offers several advantages for
studying CRC screening use because it provides complete
information on which tests are used. For example, NHIS
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respondents were asked to identify the type of test used
during their last colorectal examination (e.g., sigmoi-
doscopy, colonoscopy). Other national surveys, including
the Medical Expenditure Panel Survey (MEPS) and
Behavioral Risk Factor Surveillance System (BRFSS), do
not differentiate between sigmoidoscopy and colonoscopy.
Therefore, it is not feasible to study the use of colonoscopy,
which is a much less well-studied test than FOBT and sig-
moidoscopy. In addition, reports using MEPS or BRFSS
are more likely to obtain higher estimates when a 10-year
time frame is used to assess adherence for sigmoidoscopy
and colonoscopy. Our rates of use and adherence were
somewhat lower than those in BRFSS (25).
Future research should continue the search for other
important predictors of CRC screening use. The current
model could be extended further to examine health plan
factors, contextual factors, and policy impact. Prior
research found that individual health plan characteristics
may influence the use of breast and cervical cancer screen-
ing services (26-28). Less is known about whether and how
health plan factors influence CRC screening use. There is
also a growing recognition that contextual factors (e.g., pri-
mary care physicians’ beliefs and recommendations about
CRC screening in the area where an individual lives,
capacity for endoscopic CRC screening in the area of resi-
dence, the prevalence of managed care in an area where an
individual lives) may affect the use of health services
(18,29-32), but little is known about the extent to which
CRC screening use is influenced by contextual factors.
Finally, more research is needed to understand how poli-
cies, such as expanding Medicare coverage for colonoscopy
screening, affect use of specific CRC tests over time.
This study has several limitations: 1) self-reported data
may be inaccurate, although a prior study found good
agreement between self-reported data and medical records
for sigmoidoscopy and colonoscopy (33); 2) because it was
not feasible for us to identify colonoscopies performed for
diagnostic purposes (e.g., prompted by symptoms, done as
a follow-up to other abnormal tests results) from those
done only for screening, our estimates are higher than
those in studies that examine CRC screening tests only
(respondents may also inaccurately identify reasons for
testing [33]); 3) we were unable to examine other key pre-
dictors identified in the literature (e.g., test preferences of
patients and physicians, physician recommendations, sup-
ply-side factors such as capacity of local health care facili-
ties for CRC screening) because NHIS lacks such data.
(Information on physicians’ recommendations was collect-
ed only in the 2000 NHIS and only for respondents who
were never screened or who were not screened within the
recommended time frame.)
Rates of ever screened and up-to-date screening have
increased between 2000 and 2003 but only modestly.
Although screening rates remain low, most people who get
screened at all are up-to-date with screening. We found
that predictors of screening were stable over time despite
changes in CRC screening policies. The most influential
socioeconomic predictors are having insurance coverage, a
higher income, a usual source of care, and a dental visit in
the past year. Further research is needed to uncover bar-
riers to CRC screening and to develop strategies to over-
come these barriers.
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Table 1. Unadjusteda Rates of Colorectal Cancer Screening Among Adults Aged 50 Years and Older in the 2000 (N =11,574)
and 2003 (N =11,779) National Health Interview Surveys
Unscreened 5486 (47) 5313 (45) .10
Ever screenedcd 6088 (53) 6466 (55) .10
FOBT only 1752 (29) 1597 (25) .14
Sigmoidoscopy only 469 (8) 358 (6) .16
Colonoscopy (with or without FOBT) 2289 (38) 3428 (53) .02
FOBT and sigmoidoscopy 747 (12) 567 (9) .15
Do not know or other test 831 (14) 516 (8) .11
Not up-to-date 1942 (32) 1553 (24) .01
Up-to-date 4146 (68) 4913 (76) .01
FOBT only 1071 (26) 782 (16) .08
Sigmoidoscopy only 631 (15) 496 (10) .01
Colonoscopy (with or without FOBT) 2118 (51) 3427 (70) .05
FOBT and sigmoidoscopy 326 (8) 208 (4) .13
Up-to-date 4146 (36) 4913 (42) .03
(total samples)e
FOBT indicates fecal occult blood test.
aData were not controlled for other confounders.
bTo account for the survey design, an F statistic based on Rao and Scott correction was used instead of the X2 test.
cEver screened is defined as having ever been screened using FOBT, sigmoidoscopy, or colonoscopy.
dTest categories are mutually exclusive.
eUp-to-date screening was defined as having an FOBT in the past 12 months, a sigmoidoscopy in the past 5 years, or a colonoscopy in the past 10 years.
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Table 2. Weighteda Bivariate Associations Between Individual Characteristics and Colorectal Cancer Screening Rates Among
Adults Aged 50 Years and Older in the 2000 and 2003 National Health Interview Surveys (NHIS)
Age, y
50-64 49 .08 51 .09 67 .21 77 .48
65-74 63 66 73 78
>75 59 63 68 75
Sex
Male 54 .64 57 .47 68 .07 79 .20
Female 54 56 69 75
Race and ethnicity
Hispanic 36 .09 39 .13 68 .10 77 .36
White 57 59 69 77
African American 47 51 67 75
Other 41 40 59 71
Race
White 57 .04 59 .10 69 .09 77 .04
Nonwhite 42 45 66 75
Household income (% federal poverty level)
Low (<200) 48 .07 48 .04 66 .38 72 .17
Medium (200-399) 55 59 68 75
High (>400) 56 58 70 79
Education
<High school graduate 44 .06 45 .06 64 .20 71 .08
High school graduate 53 55 68 76
>College graduate 60 62 71 79
Dental visit in last year
Yes 60 .04 61 .01 71 .13 80 <.001
No 44 48 64 71
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Ever Screened Up-to-Date Screening 
Among Total Sample Among Ever Screened
2000, % 2003, %  2000, %  2003, % 
Variables (N = 11,574) Pb (N = 11,779) P (n = 6088) P (n = 6466) P
aData were weighted to reflect U.S. civilian, noninstitutionalized population but not for other confounders.
bTo account for the survey design, an F statistic based on Rao and Scott correction was used instead of the X2 test.
cBehavioral risk factors include 1) alcohol consumption >720 drinks per year for men and >360 drinks for women, 2) smoking, and 3) lack of physical
activity. 
dUnderweight or normal sample includes individuals with a body mass index of less than 25 kg/m2; overweight or obese sample includes individuals with a
body mass index of 25 kg/m2 or more. 
eChronic conditions include diabetes, arthritis, ulcers, cardiovascular disease, hypertension, and asthma or emphysema.
(Continued on next page)Insurance coverage 
Private 57 .04 60 .14 70 .22 78 .07
Medicare 54 57 70 77
Medicaid or other  45 51 60 76
public insurance
Uninsured 26 28 58 59
Usual source of care
Yes 56 .02 58 .04 69 .14 78 .01
No 26 25 51 50
Number of behavioral risk factorsc
0 63 .08 65 .12 73 .28 78 .25
15 3 5 5 6 8 7 7
24 7 4 7 6 4 7 4
34 2 5 2 6 4 8 3
Body mass indexd
Underweight or normal 52 .15 55 .53 69 .75 76 .66
Overweight or obese 55 57 69 77
Number of chronic conditionse
0 44 .02 44 .08 66 .18 76 .46
15 3 5 7 7 1 7 6
26 2 6 2 6 8 7 9
>36 7 6 9 6 9 7 6
Self-reported health status
Very good 53 .39 56 .41 70 .50 78 .52
Good 54 57 69 77
Fair 55 54 67 74
Poor 56 56 67 75
aData were weighted to reflect U.S. civilian, noninstitutionalized population but not for other confounders.
bTo account for the survey design, an F statistic based on Rao and Scott correction was used instead of the X2 test.
cBehavioral risk factors include 1) alcohol consumption >720 drinks per year for men and >360 drinks for women, 2) smoking, and 3) lack of physical activity. 
dUnderweight or normal sample includes individuals with a body mass index of less than 25 kg/m2; overweight or obese sample includes individuals with a body
mass index of 25 kg/m2 or more. 
eChronic conditions include diabetes, arthritis, ulcers, cardiovascular disease, hypertension, and asthma or emphysema.
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Table 2. (continued) Weighteda Bivariate Associations Between Individual Characteristics and Colorectal Cancer Screening
Rates Among Adults Aged 50 Years and Older in the 2000 and 2003 National Health Interview Surveys (NHIS)
Ever Screened Up-to-Date Screening 
Among Total Sample Among Ever Screened
2000, % 2003, %  2000, %  2003, % 
Variables (N = 11,574) Pb (N = 11,779) P (n = 6088) P (n = 6466) PVOLUME 3: NO. 4
OCTOBER 2006
Table 3. Multivariate Logistic Regression Analysis of Adjusteda Rates of Adults Aged 50 Years and Older Who Were Ever
Screened for Colorectal Cancer in the 2000 and 2003 National Health Interview Surveys (NHIS)
Age 1.03 (1.02-1.03) <.001 1.04 (1.03-1.05) <.001 3.93 (.05)
Sex
Female 1.04 (0.93-1.16) .50 0.95 (0.85-1.07) .41 .94 (.33)
Male Ref — Ref — — 
Race and ethnicity
Hispanic 0.67 (0.55-0.80) <.001 0.84 (0.70-1.02) .08 2.84 (.09)
White Ref — Ref — —
African American 0.88 (0.74-1.05) .16 0.98 (0.82-1.17) .80 .74 (.39)
Asian or other 0.68 (0.48-0.96) .03 0.44 (0.29-0.65) <.001 2.61 (.11)
Household incomed 1.03 (1.00-1.05) .003 1.06 (1.05-1.08) <.001 8.69 (.003)
Education levelc 1.06 (1.04-1.08) <.001 1.06 (1.05-1.08) <.001 .02 (.88)
Insurance coverage
Private insurance 1.76 (1.38-2.24) <.001 1.61 (1.27-2.05) <.001 .13 (.72)
Medicare 1.54 (1.15-2.05) .003 1.41 (1.06-1.87) .02 .09 (.76)
Medicaid or other public insurance 1.37 (1.04-1.81) .02 1.99 (1.44-2.50) <.001 4.24 (.04)
Uninsured Ref — Ref —  — 
Having usual source of care
Yes 2.21 (1.76-2.76) <.001 2.06 (1.63-2.61) <.001 .27 (.60)
No Ref — Ref — —
Dental visit in last year
Yes 1.66 (1.47-1.87) <.001 1.43 (1.28-1.61) <.001 3.51 (.06)
No Ref — Ref —  —
Number of behavioral risk factorse 0.86 (0.80-0.93) <.001 0.81 (0.75-0.87) <.001 1.10 (.30)
Number of chronic conditionsf 1.36 (1.30-1.43) <.001 1.37 (1.31-1.44) <.001 .01 (.94)
OR indicates odds ratio; CI, confidence interval; Ref, reference group.
aData were weighted to reflect the U.S. civilian, noninstutionalized population for each year and SE adjustment to account for the complex survey design.
bSignificant P values (<.05) reject the null hypothesis that the coefficient in the 2000 model is equal to the coefficient in the 2003 model. 
cAge and education were treated as continuous variables and were measured in years (age range, 50 to 85 years; mean 64, SE = 10.62). 
dPoverty level was treated as an ordinal variable and ranged from 1 to 14, with 1 = under 50% poverty level and 14 = 500% or greater. 
eBehavioral risk factors include 1) alcohol consumption >720 drinks per year for men and >360 drinks for women, 2) smoking, and 3) lack of physical activity. 
fChronic conditions include diabetes, arthritis, ulcers, cardiovascular disease, hypertension, and asthma or emphysema.
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Adults Ever Screened for Colorectal Cancera
2000 2003
(n = 8377) (n = 8271) β2000:2003
Correlates OR (95% CI) P OR (95% CI) P Wald F test1,339 (P)bTable 4. Multivariate Logistic Regression Analysis of Adjusteda Rates of Adults Aged 50 Years and Older Who Are Up-to-Date
for Colorectal Cancer Screening in the 2000 and 2003 National Health Interview Surveys (NHIS)a
Agec 1.00 (1.00-1.01) .22 1.00 (1.00-1.01) .34 .12 (.73)
Sex
Female 0.94 (0.84-1.10) .46 0.89 (0.76-1.05) .16 .13 (.72)
Male Ref — Ref —  — 
Race and ethnicity
Hispanic 1.20 (0.91-1.59) .20 1.26 (0.93-1.69) .14 .00d (.99)
White Ref — Ref — — 
African American 1.00 (0.78-1.28) .97 1.05 (0.80-1.37) .72 .04 (.84)
Asian or other 0.65 (0.39-1.09) .10 0.88 (0.52-1.48) .63 .80 (.37)
Household incomee 1.00 (0.98-1.03) .10 1.03 (1.01-1.06) .01 2.24 (.14)
Education levelc 1.03 (1.00-1.06) .02 1.04 (1.00-1.07) .007 .00f (.98)
Insurance coverage
Private insurance 1.39 (0.98-1.99) .07 1.68 (1.13-2.50) .01 .45 (.50)
Medicare 1.50 (1.01-2.23) .05 2.07 (1.34-3.19) <.001 .82 (.37)
Medicaid or other public insurance 1.10 (0.72-1.68) .66 2.18 (1.42-3.35) <.001 4.14 (.04)
Uninsured Ref — Ref —  — 
Having usual source of care
Yes 2.05 (1.43-2.95) <.001 2.59 (1.70-3.94) <.001 .25 (.62)
No Ref — Ref —  — 
Dental visit in last year
Yes 1.32 (1.12-1.57) .001 1.47 (1.21-1.78) <.001 .13 (.72)
No Ref — Ref —  — 
Number of behavioral risk factorsg 0.84 (0.75-0.94) .003 0.99 (0.87-1.12) .84 4.31 (.04 )
Number of chronic conditionsh 1.02 (0.96-1.08) .56 1.06 (0.99-1.14) .19 .44 (.51 )
OR indicates odds ratio; CI, confidence interval; Ref, reference group.
aData were weighted to reflect the U.S. civilian, noninstutionalized population for each year and SE adjustment to account for the complex survey design.
bSignificant P values (<.05) reject the null hypothesis that the coefficient in the 2000 model is equal to the coefficient in the 2003 model. 
cAge and education were treated as continuous variables and were measured in years (age range, 50 to 85 years; mean, 64, SE = 10.62). Education F test value
= .000507. 
dHispanic F test value = .000075. 
ePoverty level was treated as an ordinal variable and ranged from 1 to 14, with 1 = under 50% federal poverty level and 14 = 500% or greater. 
fEducation F test value = .000507. 
gBehavioral risk factors include 1) alcohol consumption >720 drinks per year for men and >360 drinks for women, 2) smoking, and 3) lack of physical activity. 
hChronic conditions include diabetes, arthritis, ulcers, cardiovascular disease, hypertension, and asthma or emphysema.
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Adults Up-to-Date for Colorectal Cancer Screening
2000 2003
(n = 4459) (n = 4694) β2000:2003
Correlates OR (95% CI) P OR (95% CI) P Wald F test1,339 (P)b